Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
The standard of care for pancreatic cancer has remained largely unchanged for the past two decades, but now scientists have identified 10 different genetic pathways driving the disease,…
As telemedicine platforms and wearable health/activity monitors continue to proliferate, the possible use-cases continue to grow. The applications for improving access to healthcare in more rural areas and…
